Clinical characteristics and treatment patterns among US patients with HIV

Julie L Priest1, Tanya Burton, Cori Blauer-Peterson

  • 1ViiV Healthcare, 5 Moore Dr, Durham, NC 27709.

Insights

People with HIV-1 and Medicare insurance face higher pill burdens and more comorbidities. Treatment selection for HIV-1 should consider individual patient complexities like comorbidities and pill burden.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Health Services Research

Background:

  • Antiretroviral therapy (ART) has transformed HIV-1 management, improving life expectancy and quality of life.
  • Understanding treatment patterns and clinical characteristics in diverse patient populations is crucial for optimizing care.
  • Health insurance type can influence access to and patterns of care for chronic conditions like HIV-1.

Purpose of the Study:

  • To describe the clinical characteristics and treatment patterns of patients with HIV-1.
  • To compare these characteristics between patients with commercial insurance and those with Medicare in the United States.
  • To identify factors influencing treatment complexity, such as comorbidities and pill burden.

Main Methods:

  • Retrospective cohort study utilizing administrative claims data from 2007 to 2017.
  • Included adult commercial and Medicare health plan enrollees with evidence of HIV-1 and ART.
  • Identified ART regimens using a claims-based algorithm and stratified results by treatment status and insurance type.

Main Results:

  • A cohort of 18,699 patients with HIV-1 was analyzed; 82% had commercial insurance.
  • Patients with Medicare insurance or multiple ART regimens experienced a higher daily pill burden.
  • Common comorbidities included hyperlipidemia, cardiovascular disease, hypertension, depression, and anxiety.

Conclusions:

  • Patients with HIV-1 enrolled in Medicare exhibit significant comorbidities and a high total pill burden.
  • Effective HIV-1 management requires consideration of individual complexities, including comorbidities and pill burden, when selecting ART regimens.
  • Despite advancements in ART, personalized treatment approaches are essential for improving outcomes in people living with HIV.
Abstract

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.1K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
799
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
148
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
235
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.8K